1. Home
  2. MFI vs BCDA Comparison

MFI vs BCDA Comparison

Compare MFI & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFI
  • BCDA
  • Stock Information
  • Founded
  • MFI 2002
  • BCDA N/A
  • Country
  • MFI Hong Kong
  • BCDA United States
  • Employees
  • MFI N/A
  • BCDA N/A
  • Industry
  • MFI
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFI
  • BCDA Health Care
  • Exchange
  • MFI NYSE
  • BCDA Nasdaq
  • Market Cap
  • MFI 9.9M
  • BCDA 7.9M
  • IPO Year
  • MFI 2024
  • BCDA N/A
  • Fundamental
  • Price
  • MFI $0.66
  • BCDA $2.72
  • Analyst Decision
  • MFI
  • BCDA Strong Buy
  • Analyst Count
  • MFI 0
  • BCDA 1
  • Target Price
  • MFI N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • MFI 289.3K
  • BCDA 53.2K
  • Earning Date
  • MFI 02-24-2025
  • BCDA 03-26-2025
  • Dividend Yield
  • MFI N/A
  • BCDA N/A
  • EPS Growth
  • MFI N/A
  • BCDA N/A
  • EPS
  • MFI N/A
  • BCDA N/A
  • Revenue
  • MFI $3,877,747.00
  • BCDA $71,000.00
  • Revenue This Year
  • MFI N/A
  • BCDA N/A
  • Revenue Next Year
  • MFI N/A
  • BCDA N/A
  • P/E Ratio
  • MFI N/A
  • BCDA N/A
  • Revenue Growth
  • MFI N/A
  • BCDA N/A
  • 52 Week Low
  • MFI $0.51
  • BCDA $1.63
  • 52 Week High
  • MFI $14.49
  • BCDA $8.85
  • Technical
  • Relative Strength Index (RSI)
  • MFI N/A
  • BCDA 64.47
  • Support Level
  • MFI N/A
  • BCDA $2.27
  • Resistance Level
  • MFI N/A
  • BCDA $2.78
  • Average True Range (ATR)
  • MFI 0.00
  • BCDA 0.28
  • MACD
  • MFI 0.00
  • BCDA 0.03
  • Stochastic Oscillator
  • MFI 0.00
  • BCDA 91.04

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: